| 标题 |
14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet 作者:Sakakida T, Taniguchi H, Asayama M, Suwa Y, Shimura T, Mitani S, Makiyama A, Arai H, Matsuoka H, Yokota M, Takano Y, Kato K, Oda H, Kajiwara T, Ogawa K, Shibata N, Sawada K, Yomoda T, Kudo T, Okuda H, Okumura Y, Tanaka C, Nakamura M, Tsuda T, Kitajima T, Tsukuda H, Shinozaki E, Furuta M, Kashiwada T, Okuya K, Mushiake H, Hasegawa J, Nihei K, Mizushima T, Mine T, Mizukami T, Kudo C, Mishima A, Murotani K, Masuishi T, PRABITAS investigators 出版日期:2026-10-24 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)